Loricrin (TG3) - Revision history

Bernadett at 12:04, 10 March 2015

2015-03-10T12:04:35Z

WikiSysop at 14:20, 7 January 2008

2008-01-07T14:20:36Z

WikiSysop at 15:24, 17 August 2007

2007-08-17T15:24:56Z

WikiSysop at 05:55, 25 July 2007

2007-07-25T05:55:15Z

WikiSysop: New page: {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | align="center" colspan="2...

2007-07-25T05:55:02Z

New page: {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | align="center" colspan="2...

New page

{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
! {{infobox header}}| '''{{PAGENAME}}'''
|-
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:{{PAGENAME}}.png|200px|{{PAGENAME}}]]
|-
| Substrate peptide name
| {{PAGENAME}}
|-
| Synonyms
| -
|-
| Determination type
| In situ
|-
| Source
| Homo sapiens
|-
| Subcellular localization
| Cornified envelope
|-
| Swissprot ID
| [http://au.expasy.org/uniprot/P23490 P23490 ]
|-
| Reactive glutamines
| Q3, Q6, Q10, Q153, '''Q156, Q215''', Q216, '''Q219''', Q225, Q303, Q305, Q306, Q308
|-
| Reactive lysines
| '''K4''', K5, '''K88''', '''K307''', '''K315'''
|-
| Substrate sequence
| SY''QKKQ''PTP''Q''PPV

SGGSV''K''YSGGG

FSG''Q''AV''Q''CQSY

YVSS''QQ''VT''Q''TSCA

AP''Q''PSYGGG

CH''Q''T''QQKQ''APTWPS''K''
|-
| Structure
| No available crystal structure
|-
| Surface accessibility
|
|-
| Disorder prediction
| [http://iupred.enzim.hu/index.html IUPred]
|-
| Reference
| [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=2007607&dopt=Abstract PMID:2007607]
[http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=9482839&dopt=Abstract PMID:9482839]
[http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=8999895&dopt=Abstract PMID:8999895]
|-
| Notes
| Residues in bold have been determined as in situ substrates of TG3

|-
| {{infobox header}} |
|-
|}

[[Category:Epidermal transglutaminase|*]]

@@ Line 1: / Line 1: @@
 {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
-! {{infobox header}}| '''{{PAGENAME}}'''
+! {infobox header}| '''{{PAGENAME}}'''
 |-
 | Substrate peptide name
@@ Line 57: / Line 57: @@
 |-
-| {{infobox header}} |
+| {infobox header} |
 |-
 |}
 [[Category:Epidermal transglutaminase|*]]

@@ Line 5: / Line 5: @@
 |-
 | Substrate peptide name
-| {{PAGENAME}}
+| Loricrin
 |-
 | Synonyms

@@ Line 11: / Line 11: @@
 |-
 | Determination type
-| In situ
+| In situ/In vitro
 |-
 | Source